Japan's Terumo Said to Bid for Abbott's (ABT) Medical Device Business - Nikkei
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Japan's Terumo is looking to purchase Abbott's (NYSE: ABT) medical device business, according to Nikkei. Terumo bid for the cardiovascular device segment and operations, the report said. The deal could be valued at $1.47 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TGP Exits $2B Race for McDonald's (MCD) China Business - Bloomberg
- Deutsche Bank could integrate Postbank in strategic u-turn: sources
- Concho Resources (CXO), PE Investors Seek Buyer for Pipeline System Alpha Crude Connector - DJ
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!